Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON

I Leader della Finanza

Ultime notizieSocietÓMercatiEconomia & ForexMaterie PrimeTassiLeader della FinanzaPro. della FinanzaAgendaSettori 
HomeTutte le notizieLe notizie pi¨ letteBiografie dei Leader della finanza
Portrait de Adrian Adams
EtÓ : 69
Patrimonio pubblico : 867 434 USD
Principali societÓ : Akebia Therapeutics, Inc. - Impel NeuroPharma, Inc. - AcelRx Pharmaceuticals, Inc.
Riassunto 
Adrian Adams is a businessperson who has been at the helm of 13 different companies and currently occupies the position of Chairman, President & Chief Executive Officer at Impel NeuroPharma, Inc., Chairman at Akebia Therapeutics, Inc. and Chairman for AcelRx Pharmaceuticals, Inc.

In his past career Mr. Adams was Chairman & Chief Executive Officer of Neurologix, Inc., Chief Executive Officer for Aralez Pharmaceuticals Plc, Chief Executive Officer & Director at Aralez Pharmaceuticals, Inc. and Chief Executive Officer & Director at POZEN, Inc. (a subsidiary of Aralez Pharmaceuticals, Inc.), Director-Sales & Marketing at AstraZeneca, Inc., President & Chief Executive Officer of Sunovion Pharmaceuticals, Inc., President & Chief Executive Officer at KOS Pharmaceuticals, Inc., President, Chief Executive Officer & Director at Inspire Pharmaceuticals, Inc., President, Chief Executive Officer & Director at Auxilium Pharmaceuticals LLC, President & Chief Executive Officer at Smithkline Beecham Plc and President & Chief Executive Officer at Novartis Pharmaceuticals UK Ltd.

He received an undergraduate degree from The University of Manchester and an undergraduate degree from the University of Salford.


Posti e reponsabilitÓ di Adrian Adams 
NomeTitolo Da
Akebia Therapeutics, Inc.
(Biotecnologia)
Chairman 2018
Impel NeuroPharma, Inc.
(Biotecnologia)
Chairman, President & Chief Executive Officer 2020
AcelRx Pharmaceuticals, Inc.
(Biotecnologia)
Chairman 2013


Participazioni di Adrian Adams 
NomeAzioni%Valorizzazione
Impel NeuroPharma, Inc. (IMPL)
(Biotecnologia)
20 0000,10%379 800 USD
Akebia Therapeutics, Inc. (AKBA)
(Biotecnologia)
91 1000,052%267 834 USD
AcelRx Pharmaceuticals, Inc. (ACRX)
(Biotecnologia)
196 2500,16%219 800 USD


Adrian Adams: network personale 
Le notizie pi¨ lette 
15/09BRAD SMITH: Microsoft annuncia il riacquisto di azioni fino a 60 miliardi di dollari e aumenta il dividendo
MR
13/09MARTIN SORRELL: S4 Capital di Sorrell alza le prospettive di profitto al 40%
MR
14/09STEPHEN SCHERR: Goldman Sachs nomina Coleman come nuovo CFO, sostituendo Scherr
MR
21:58WILLIAM ACKMAN: Il fondo Pershing Square di Ackman sale mentre Universal sale al debutto in borsa
MR
20/09GIUSEPPE CASTAGNA: Banco Bpm, non ci sono presupposti per consolidamento - Castagna a Corriere
RE
08/09MICHAEL O'LEARY: Ryanair, aeroporti britannici in difficoltà a Natale - O'Leary
RE
15/09FRANCESCO GAETANO CALTAGIRONE: Generali, Caltagirone aumenta quota di ulteriore 0,11%, sale sopra 6%
RE
09/09FRANCESCO GAETANO CALTAGIRONE: Generali, Caltagirone arrotonda quota a 6,1%
RE
18:54JOHN ELKANN: Stellantis, Torino è città chiave per produzione gruppo - Elkann
RE
15:21LEONARDO DEL VECCHIO: Generali, Del Vecchio arrotonda quota al 5,1%, patto con Caltagirone al 12,5%
RE
Pi¨ notizie


© 2021 People and Ownership :   
Adrian Adams : connessioni